
Rachel Presti
Victoria Fraser, MD, Adolphus Busch Professor of Medicine and Chair of the Department of Medicine July 28, 2026 · Washington University/B-JH/SLCH Consortium
Credentials: · · · · ·
History
PresentMD Department · Washington University/B-JH/SLCH Consortium
PresentInfectious Diseases Clinical Research Unit · Washington University/B-JH/SLCH Consortium

Research
Nature Medicine · 2021 · 800 citations
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
Nature · 2021 · 697 citations
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
Nature · 2021 · 405 citations

42 papers

16 papers

16 papers

16 papers
- ST
14 papers

11 papers

11 papers

11 papers
Grants
- 2024–2029
Mechanisms of Immune Protection Against Respiratory Viruses
National Institute of Allergy and Infectious Diseases · U19
Project lead · $1.5M · Washington University
- 2007–2027
Vanderbilt HIV Clinical Trials Unit (CTU)
National Institute of Allergy and Infectious Diseases · UM1
PI · $24.1M · Vanderbilt University Medical Center
- 2013–2019
Molecular Mechanisms of Chronic Airway and Alveolar Disease in Hiv
National Heart, Lung, and Blood Institute · U01
PI · $3.1M · Washington University
- 2008–2012
The Role of NKG2D/DAP10 in Toxoplasma Gondii Infection
National Institute of Allergy and Infectious Diseases · K08
Contact PI · $337.3K · Washington University
Clinical trials
- 2023–2025
Washington University WU 409: Immune Responses to Rabies Vaccine.
Principal investigator · Completed · Early phase 1
Washington University School of Medicine
- 2020–2022
Principal investigator · Terminated · Early phase 1
Washington University School of Medicine
- 2018–2025
Maraviroc on HIV-1 Infected Subjects Who Require Allogeneic Hematopoietic Cell Transplant
Principal investigator · Withdrawn · Phase 1
Washington University School of Medicine
- 2026–2027
Menopausal HT for Women Living With HIV (HoT)
Site PI · Recruiting · Phase 4
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections


